Clinical Trial Update: Extension Study To Evaluate The Long-Term Safety, Tolerability, And Efficacy Of Low And High Doses Of Bl-1020 [Phase 2]

View source ↗

Summary

An extension phase 2 study of Bl-1020 in schizophrenia evaluating long-term safety, tolerability, and efficacy at low and high doses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Bl-1020

Snippet

Sponsor: BioLineRx, Ltd. | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED